XML 27 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2012   30,902,000        
Beginning Balance at Dec. 31, 2012 $ 209,123 $ 3 $ 244,924 $ (3,082) $ (32,722) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   2,362.000        
Vesting of restricted stock (in shares)   180,613.000        
Vesting of restricted stock (300) $ 0 (300)      
Tax deficit of share-based compensation (399)   (399)      
Equity compensation 2,100   2,100      
Foreign currency translation adjustment, net of deferred taxes (224)     (224)    
Reclassification of currency translation adjustments 2,336     2,336    
Net income (51,969)       (51,969)  
Ending Balance (in shares) at Dec. 31, 2013   31,085,000        
Ending Balance at Dec. 31, 2013 160,667 $ 3 246,325 (970) (84,691) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   66,119.000        
Vesting of restricted stock (in shares)   141,188.000        
Vesting of restricted stock (245)   (245)      
Equity compensation 1,387   1,387      
Foreign currency translation adjustment, net of deferred taxes (148)     (148)    
Acquisition 324         324
Reclassification of currency translation adjustments 0          
Distribution to noncontrolling shareholder (119)         (119)
Net income (31,534)       (31,783) 249
Ending Balance (in shares) at Dec. 31, 2014   31,292,000        
Ending Balance at Dec. 31, 2014 $ 130,332 $ 3 247,467 (1,118) (116,474) 454
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 293,625 119,000        
Vesting of restricted stock (in shares)   191,000        
Vesting of restricted stock $ (543)   (543)      
Equity compensation 2,460   2,460      
Foreign currency translation adjustment, net of deferred taxes (89)     (89)    
Acquisition of Mediscan (in shares)   350,000        
Acquisition of Mediscan 4,724   4,724      
Reclassification of currency translation adjustments 0          
Distribution to noncontrolling shareholder (494)         (494)
Net income 4,954       4,418 536
Ending Balance (in shares) at Dec. 31, 2015   31,952,000        
Ending Balance at Dec. 31, 2015 $ 141,344 $ 3 $ 254,108 $ (1,207) $ (112,056) $ 496